找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: High-Density Lipoproteins as Biomarkers and Therapeutic Tools; Volume 2. Improvemen Kyung-Hyun Cho Book 2019 Springer Nature Singapore Pte

[復(fù)制鏈接]
查看: 11566|回復(fù): 35
樓主
發(fā)表于 2025-3-21 16:31:45 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools
副標(biāo)題Volume 2. Improvemen
編輯Kyung-Hyun Cho
視頻videohttp://file.papertrans.cn/427/426564/426564.mp4
概述Provides up-to-date information on means of improving HDL.Examines enhancement of HDL functionality by policosanol.Discusses the latest clinical applications of HDL
圖書封面Titlebook: High-Density Lipoproteins as Biomarkers and Therapeutic Tools; Volume 2. Improvemen Kyung-Hyun Cho Book 2019 Springer Nature Singapore Pte
描述This book is the second of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. In this volume, the focus is on the improvement of HDL, enhancement of its functionality, and the use of HDL for therapeutic purposes. In the first section, up-to-date information is provided on such topics as the tumor regression-promoting and antidiabetic activities of reconstituted HDL containing V156K apolipoprotein A-I, the enhancement of HDL effects by high doses of vitamin C, the benefits derived from incorporation of growth hormones 1 and 2 into rHDL, and the biological functions of omega-3 linolenic acid in rHDL. The enhancement of HDL functionality by policosanol and the resultant benefits are thoroughly examined in a separate section. Readers will also find the latest information on clinical applications of HDL. Here, specific topics include the enhancement of adenoviral gene delivery and the delivery of rapamycin. In documenting the latest knowledge in this field, this volume will be of inter
出版日期Book 2019
關(guān)鍵詞HDL, High Density Lipoproteins; HDL metabolism; HDL-Cholesterol; human disease; aging process; biomarker;
版次1
doihttps://doi.org/10.1007/978-981-13-7383-1
isbn_softcover978-981-13-7385-5
isbn_ebook978-981-13-7383-1
copyrightSpringer Nature Singapore Pte Ltd. 2019
The information of publication is updating

書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools影響因子(影響力)




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools影響因子(影響力)學(xué)科排名




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools網(wǎng)絡(luò)公開度




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools被引頻次




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools被引頻次學(xué)科排名




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools年度引用




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools年度引用學(xué)科排名




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools讀者反饋




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:36:48 | 只看該作者
HDL as Therapeutic Tools,thout any observed toxicity at therapeutic doses (Oda et al. 2006). These reports have demonstrated that rHDL might be utilized as efficient drug and gene delivery vehicles for therapeutic agents, owing to the ability of peripheral cells to acquire HDL core components.
板凳
發(fā)表于 2025-3-22 03:35:39 | 只看該作者
ific topics include the enhancement of adenoviral gene delivery and the delivery of rapamycin. In documenting the latest knowledge in this field, this volume will be of inter978-981-13-7385-5978-981-13-7383-1
地板
發(fā)表于 2025-3-22 04:36:06 | 只看該作者
High-Density Lipoproteins as Biomarkers and Therapeutic ToolsVolume 2. Improvemen
5#
發(fā)表于 2025-3-22 11:03:18 | 只看該作者
High-Density Lipoproteins as Biomarkers and Therapeutic Tools978-981-13-7383-1
6#
發(fā)表于 2025-3-22 15:29:13 | 只看該作者
7#
發(fā)表于 2025-3-22 18:42:41 | 只看該作者
8#
發(fā)表于 2025-3-22 23:12:29 | 只看該作者
Enhancement of HDL by Policosanol,8) and increased longevity (Mazzotti et al. 2014; Milman et al. 2014). Policosanol (PCO) supplementation is widely used in Central America and Latin America to treat dyslipidemia and manage cardiovascular burden. PCO is mixture of eight aliphatic primary alcohols refined from sugarcane wax (. L.). I
9#
發(fā)表于 2025-3-23 02:08:50 | 只看該作者
10#
發(fā)表于 2025-3-23 07:17:44 | 只看該作者
Book 2019he changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. In this volume, the focus is on the improvement of HDL, enhancement of its functionality, and the use of HDL for therapeutic purposes. In the first section, up-to-date
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 17:30
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
来凤县| 瑞金市| 高青县| 万安县| 兴国县| 陇西县| 紫云| 建瓯市| 宕昌县| 红桥区| 隆化县| 缙云县| 营山县| SHOW| 洛川县| 洛南县| 东海县| 莱西市| 西宁市| 镇远县| 包头市| 射阳县| 遵化市| 河西区| 石柱| 桦甸市| 辉南县| 班玛县| 林周县| 平乐县| 桦川县| 武川县| 宁南县| 莱西市| 贵阳市| 连云港市| 江川县| 南陵县| 涟源市| 西贡区| 民权县|